ArticleAnnals of surgical oncology2020

ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified.

Anne Brecht Francken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.